hCG
Human chorionic gonadotropin · Pregnyl · Novarel · Ovidrel (recombinant choriogonadotropin alfa)
FDA-APPROVED · PLACENTAL GLYCOPROTEIN HORMONE (FDA-APPROVED); LH-RECEPTOR AGONIST
▓ 243 indexed citations across PubMed (186), ClinicalTrials.gov (18), EuropePMC (39).
Citation breakdown by evidence tier
← weaker evidence · stronger evidence →
Tap any tier to jump to that section of the bibliography.
Mechanism of action
LH-receptor agonist with minor FSH-like activity; in males stimulates testicular Leydig cells to produce endogenous testosterone; in females maintains corpus luteum progesterone production and triggers ovulation
Researched effects
FDA-approved: female anovulatory infertility / ovulation induction; prepubertal cryptorchidism; selected hypogonadotropic hypogonadism. Off-label clinical use: intratesticular testosterone preservation during exogenous-T therapy; spermatogenesis restoration; HPG restart-stack protocols
Live evidence
FDA label safety
CONTRAINDICATIONS Prior hypersensitivity reactions to human gonadotropins, including hCG, or any of the excipients (see ADVERSE REACTIONS ). High serum FSH, indicating primary gonadal failure in women. Presence of uncontrolled non-gonadal endocrinopathies (e.g., thyroid, adrenal, or pituitary disorders). Tumors of the hypothalamus or pituitary gland and ovary, breast, or uterus in females and breast or prostate in males. Malformations of the reproductive organs incompatible with pregnancy. Fibroid tumors of the uterus incompatible with pregnancy. Abnormal vaginal bleeding of undetermined…
Active clinical trials 26
- A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA)
- Verapamil In Preclinical Type 1 Diabetes
- hCG Treatment for Rehabilitation From a TBI
- Dual Trigger VS HCG Trigger for Final Oocyte Maturation in Normal Responders
- FET-LET-2x2: Clinical Pregnancy Rates After Frozen Embryo Transfer in Natural and Modified Natural Cycles
Reported adverse events 247
Events spontaneously reported to the FDA FAERS database since 2015. A report does not establish that the drug caused the event, and counts do not reflect how often it occurs. Discuss any concern with a clinician.
FDA FAERS →Recent literature
- Redefining "Normal" for hCG in postmenopausal women: 97.5th percentile reference intervals and 99th percentile thresholds across four chemiluminescence immunoassay systems.
- 2,000 IU hCG is the optimal dose in a dual hCG/GnRH agonist trigger to achieve comparable pregnancy rates to hCG alone in fresh embryo transfers.
- Impact of fertility treatments on headache disorders: a systematic review with an overview of treatment modalities.
Live signals refreshed daily. Current as of November 19, 2026.
Dosing reported in literature
Female ovulation trigger: 5,000-10,000 USP units IM single dose 1 day after final gonadotropin (FDA Pregnyl/Novarel label). Male off-label: 250 IU SC 2x weekly TRT adjunct (Bhasin Endocrine Society 2018 starting dose, may go higher per response); 1,000 IU IM 2x weekly HPG restart (Crisler protocol starting dose)
→ FDA Pregnyl/Novarel prescribing information (female trigger); Bhasin S et al. Endocrine Society 2018 testosterone guideline (PMID 29562364); Crisler HPG-restart protocol
Known concerns
Ovarian hyperstimulation syndrome (OHSS); thromboembolism; gynecomastia (males at high dose); arterial-thrombosis case reports; contraindicated in suspected/confirmed prostate or other androgen-dependent neoplasia; precocious puberty risk in pediatric use
Top-ranked picks
10 pre-curated authoritative sources, ranked by journal tier and study weight.
- GnRH Agonist with Low-Dose hCG (Dual Trigger) versus GnRH Agonist Only Trigger in High Responders in GnRH Antagonist Cycle: A Systematic Review and Meta-Analysis.
- Recurrent miscarriage and hCG supplementation: a review and metaanalysis.
- First trimester biochemical screening for Down syndrome: free beta hCG versus intact hCG.
- Oocyte maturation triggering in high responders in IVF treatment: a systematic review and network meta-analysis
- Diagnostic accuracy of initial serum β-hCG in predicting pregnancy outcomes post-SET in IVF/ICSI cycles: a systematic review and meta-analysis
- Impact of fertility treatments on headache disorders: a systematic review with an overview of treatment modalities.
- Recombinant hCG versus dual triggering for final oocyte maturation in ICSI cycles among poor responders with endometriosis.
- hCG promotes secondary ovulation and supplementary corpus luteum formation during early pregnancy in mares.
- Phase 3 Trial to Evaluate the Efficacy and Safety of COL-1620 Vaginal Progesterone Gel
- hCG Priming in Women With Diminished Ovarian Reserve
Full citation library
Year distribution
No references match — clear filters.
Meta-Analyses
5-
1.
Human chorionic gonadotropin (hCG) has been used to prevent subsequent miscarriages after previous recurrent miscarriages. In addition to the luteotrophic effects, hCG has uterine immune and autocrine actions. hCG also affects cytokine expression. A Cochrane database systematic review has indicated that hCG seems to prevent further miscarriages, (OR for miscarriage = 0.26, 95% CI 0.14-0.52). However, the trials in the Cochrane database were not matched for the number of miscarriages, 1°, 2° or 3…
-
2.
To compare free beta hCG versus intact hCG in first trimester Down syndrome screening we analysed 63 cases of Down syndrome and 400 unaffected control pregnancies between 10 and 13 weeks' gestation. The Down syndrome median multiple of the median (MoM) was significantly higher (p=0.001) for free beta hCG (1.89 MoM) than for intact hCG (1.37 MoM). Although distributions for free beta hCG (unaffected, 0.2157; DS, 0.2322) are wider than for intact hCG (unaffected, 0.1697; DS, 0.2158), overall 27% o…
- 3.
- 4.
-
5.
Ovarian hyperstimulation syndrome (OHSS) remains a serious complication of assisted reproductive technology, particularly in high ovarian responders. Although a GnRHa-only trigger effectively minimizes the risk of OHSS, it has been associated with reduced oocyte yield and, in some reports, lower oocyte maturity, and may also compromise luteal function. Dual trigger, combining GnRHa with low-dose human chorionic gonadotropin (hCG), was developed to enhance reproductive outcomes; however, concerns…
Systematic Reviews
1- 6.
Randomised Controlled Trials
3-
7.
The objective of this study was to compare the bioavailability of s.c. and i.m. administration of human chorionic gonadotrophin (HCG; Pregnyl). In a randomized, single-centre, three-way cross-over study, 18 healthy pituitary-suppressed volunteers were assigned to single HCG injections of 5000 and 10,000 IU i.m. and 10,000 IU s.c. Rate (Cmax, t(max)) and extent [area under curve from zero to infinity (AUC(0-infinity))] of absorption of HCG were determined. Serum immunoactive HCG increased from 0.…
-
8.
This double-blind randomized clinical trial compared recombinant human chorionic gonadotropin (rhCG) alone with dual triggering (gonadotropin-releasing hormone agonist plus rhCG) for final oocyte maturation in women with endometriosis and poor ovarian response (Bologna criteria) undergoing intracytoplasmic sperm injection. A total of 152 eligible women were randomized (1:1) to receive either rhCG (250 μg) plus placebo (n = 76) or rhCG (250 μg) plus GnRH agonist (0.2 mg; n = 76). Ultimately, 128…
-
9.
This study evaluated whether the administration of human chorionic gonadotropin (hCG) during early pregnancy accelerates ovulatory dynamics and alters serum progesterone concentrations in mares with dominant follicles. Thirty pregnant embryo-recipient mares with follicles ≥35 mm during early gestation were randomly assigned to receive either 1500 IU hCG IV (hCG group; n = 17) or saline solution IV (control group; n = 13). Mares were monitored by serial ultrasonography to determine the ovulatory…
Clinical Trials
1-
10.
The current study was designed to compare blood and cerebrospinal fluid (CSF) pharmacokinetic characteristics of two forms of human chorionic gonadotropin (hCG): Pregnyl(R), derived from human urine, and Ovitrelle(R) a recombinant form. Two separate groups, each with six older male human subjects, were dosed with either form of the drug at 10,000 IU intramuscularly (IM), and followed over a 36-hour period. No significant difference in the serum level of hCG was observed for either preparation of…
Trial Registrations (ClinicalTrials.gov)
18-
11.
Conditions: Infertility, OHSS
-
12.
Conditions: Embryonic Development, Pregnancy, VEGF
-
13.
Conditions: Luteal Hormone Supplementation in In-vitro Fertilization, Embryo Transfer
-
14.
Conditions: Embryo Implantation
-
15.
Conditions: Recurrent Pregnancy Loss Without Current Pregnancy
-
16.
Conditions: Polycystic Ovary Syndrome (PCOS) Women, Polycystic Ovary Syndrome
-
17.
Conditions: Type 1 Diabetes
-
18.
Conditions: ICSI, IVF, Normal Responders (+5)
-
19.
Conditions: Infertility Female, Frozen Embryo Transfer (FET)
-
20.
Conditions: Luteal Phase Insufficiency
-
21.
Conditions: Traumatic Brain Injury
-
22.
Conditions: Obesity, Maternal
-
23.
Conditions: Infertility, Female, Ovarian Reserve, In Vitro Fertilization (IVF)
-
24.
Conditions: Low Ovarian Reserve, Poor Ovarian Response
-
25.
Conditions: Infertility (IVF Patients), Infertility Assisted Reproductive Technology, Infertile Patients (+7)
-
26.
Conditions: Threatened Miscarriage, Early Pregnancy Bleeding
-
27.
Conditions: Polycystic Ovary Syndrome (PCOS)
- 28.
Reviews
35-
29.
Hyperglycosylated hCG (hCG-H) is a glycosylation variant of the hormone hCG. Here we review all that is known about this independently functioning molecule. As discussed, it is a very different molecule to the hormone hCG. First, hCG-H is produced by cytotrophoblast cells while regular hCG is made in syncytiotrophoblast cell. Second, it is an autocrine acting directly on the cells which produce it, while regular hCG is an endocrine acting on maternal corpus luteal cells. Third, hCG-H has minimal…
-
30.
The last two decade discoveries shift the accent from consideration of human chorionic gonadotripin (hCG) as a hormone, that controls progesterone production by corpus luteum cells, to a powerful paracrine regulator which'in the tandem with its hyperglycozilated analog (hCG-H) induces successful implantation and coordinated dialog between blastocyst and uterus tissues. Ability of hCG to interact with TSH receptor and hCG-H with TGF-beta-RII extend significantly the spectrum of processes controll…
-
31.
Human chorionic gonadotropin (hCG) has four major isoforms: classical hCG, hyperglycosylated hCG, free β subunit, and sulphated hCG. Classical hCG is the first molecule synthesized by the embryo. Its RNA is transcribed as early as the eight-cell stage and the blastocyst produces the protein before its implantation. This review synthetizes everything currently known on this multi-effect hormone: hCG levels, angiogenetic activity, immunological actions, and effects on miscarriages and thyroid func…
-
32.
Measurements of human chorionic gonadotropin (hCG) synthesized by trophoblast cells is a powerful tool of pregnancy monitoring. It was showed that similarly to pregnancy also trophoblastic and nontrophoblastic malignancies produce variety of hCG molecules. In urine and serum of both pregnant women and tumors patients a fifteen various forms of hCG, such as: regular hCG, hyperglycosylated hCG and predominant hyperglycosylated hCG free β, were identified. These forms might be useful in order to re…
-
33.
The primary embryonic signal in primates is chorionic gonadotropin (CG, designated hCG in humans), that is classically associated with corpus luteum rescue and progesterone production. However, research over the past decade has revealed the presence of the hCG receptor in a variety of extragonadal tissues. Additionally, discoveries of the multiple variants of hCG, namely, native hCG, hyperglycosylated hCG (hyp-hCG) and the β- subunit of the hyperglycosylated hCG (hCG-free β) has established a ro…
-
34.
Human chorionic gonadotropin (hCG), as one of the first embryonic products, has been extensively investigated for its role in implantation and placental development. Discovery of an over-glycosylated form of this hormone, hyperglycosylated hCG (hCG-H), has provided an additional level of complexity in our understanding of the implantation and placentation process; the structure, activity and functional implications of alterations in hCG isoforms throughout pregnancy are still being characterized…
-
35.
Determination of human chorionic gonadotropin (hCG) is used for diagnosis and monitoring of pregnancy, pregnancy related disorders, for trophoblastic and some nontrophoblastic tumors. In addition, hCG is determined for doping control in males. Assay of hCG is complicated by the occurrence of different molecular forms, which are detected to various degrees by different assays. The main form of hCG in circulation and in patients with trophoblastic tumors is intact heterodimeric hCG. The free β sub…
-
36.
Hyperthyroidism or increased thyroid function has been reported in many patients with trophoblastic tumors. In these cases, greatly increased human chorionic gonadotropin (hCG) levels and suppressed TSH levels suggest that hCG has thyrotropic activity. Recent investigations have clarified the structural homology not only in the hCG and TSH molecules but also in their receptors, and this homology suggests the basis for the reactivity of hCG with the TSH receptor. The clinical significance of the…
-
37.
Human chorionic gonadotropin (hCG) is the first hormonal message from the placenta to the mother. It is detectable in maternal blood two days after implantation and behaves like an agonist of LH stimulating progesterone secretion by the corpus luteum. hCG has also a role in quiescence of the myometrium and local immune tolerance. Specific to humans, hCG is a complex glycoprotein composed of two glycosylated subunits. The α-subunit is identical to the pituitary gonadotropin hormones (LH, FSH, TSH…
-
38.
hCG is a wonder. Firstly, because hCG is such an extreme molecule. hCG is the most acidic glycoprotein containing the highest proportion of sugars. Secondly, hCG exists in 5 common forms. Finally, it has so many functions ranging from control of human pregnancy to human cancer. This review examines these molecules in detail. These 5 molecules, hCG, sulfated hCG, hyperglycosylated hCG, hCG free beta and hyperglycosylated free beta are produced by placental syncytiotrophoblast cells and pituitary…
-
39.
As a glycoprotein hormone, human chorionic gonadotropic (hCG) is not a single molecular entity but this term rather comprises an array of molecular variants such as hCG, hCG beta, hCGn, hCG beta n, hCG beta cf, -CTPhCG, hCG beta CTP, deglyhCG, asialohCG, hCGav and the closely related molecules hLH, hLH beta and hLH beta ef. The advent of monoclonal antibodies (MCA), the availability of ultrasensitive detection systems and the recent determination of the crystal structure of hCG, made it possible…
-
40.
Human chorionic gonadotropin (hCG) is no longer a single, omnipotent ovulation triggering option. Gonadotropin releasing hormone (GnRH) agonist, initially presented as a substitute for hCG, has led to a new era of administering GnRH agonist followed by hCG triggering. According to this new concept, GnRH agonist enables successful ovum maturation, while hCG supports the luteal phase and pregnancy until placental shift.
-
41.
Multiple hCG-related molecules are present in pregnancy serum and urine samples. These include non-nicked hCG (the hormone), nicked hCG, hyper- and hypoglycosylated hCG, hCG missing the C-terminal extension, free alpha-subunit, large free alpha-subunit, free beta-subunit, nicked free beta-subunit, and beta-core fragment. Over 100 immunoassays are sold for quantifying hCG-related molecules in serum or urine. Each measures nonnicked hCG and one of seven combinations of the other hCG-related molecu…
-
42.
Improved sensitivity and specificity of radioimmunoassays (RIAs) for hCG, hCG alpha and hCG beta have allowed measurements of these substances to become a powerful diagnostic aid applicable to several clinical disorders of pregnancy. In threatened abortion of the 1st trimester, the doubling time of hCG concentrations is significantly slower than in early normal pregnancies. Low levels of hCG are uniformly encountered in case of impending abortion. The overall predictive value of hCG determinatio…
-
43.
Review of the literature reveals a number of recent insights concerning the metabolic fate of human choriogonadotropin (hCG). In man, only a fraction (21.7%) of the circulating hCG molecules is excreted in urine. Results from animal studies indicate that the retained hCG is taken up by various tissues, principally kidney, liver, and ovary, where degradation occurs. Ovarian uptake is receptor mediated and saturable. Hepatic uptake of hCG is not preceded by desialylation, and blockade of hepatic r…
-
44.
To critically assess the literature on the syndrome of low-level "real" human chorionic gonadotropin (hCG), to add new cases from our practice, to enumerate the investigations that are essential in the management of these patients and to offer a working classificationfor use by physicians encountering the condition. We report our experience with 9 patients with low-level hCG treated at the Yale Trophoblast Center and discuss London and Sheffield patients as well as reports from the USA hCG Refer…
-
45.
Recent publications show that the measurements of particular human chorionic gonadotropin (hCG) variants are extremely beneficial in the diagnosis, monitoring and treatment of gestational trophoblastic disease (GTD). Here we review the possible sources of hCG and the use of commercial tests in the optimal management of GTD, quiescent GTD,false positive hCG results, placental site trophoblastic tumor (PSTT) detection, nontrophoblastic neoplasms and pituitary hCG. Hyperglycosylated hCG (hCG-H) mea…
-
46.
To review the use of hCG and to describe the clinical benefit of recombinant hCG (r-hCG) based on the published results of prospective, randomized studies. Review of published articles. Tertiary infertility care center.None.None. Oocyte number and quality, luteal phase progesterone, pregnancy and OHSS rate, and local tolerability. The published data consistently show that single doses of 250 microg r-hCG and 5,000 IU urinary (u)-hCG produce similar clinical outcomes when used in infertility trea…
-
47.
Recent advances in our understanding of hCG/hCG beta synthesis by trophoblastic and nontrophoblastic tissues together with improved techniques for measuring hCG have helped to define the role of hCG as a clinical marker. HCG determination by sensitive immunometric assay enables detection of hCG immunoreactivity in normal men and women. It facilitates early detection of normal pregnancy and significantly contributes to the diagnosis of various pregnancy-related disorders, such as ectopic pregnanc…
-
48.
Human chorionic gonadotropin (hCG) is the first hormonal message from the placenta to the mother. It is detectable in maternal blood two days after implantation and behaves like a super LH agonist stimulating progesterone secretion by the corpus luteum. In addition to maintaining the production of progesterone until the placenta itself produces it, hCG also has a role in myometrial quiescence and local immune tolerance. Specific to humans, hCG is a complex glycoprotein composed of two highly gly…
-
49.
Human chorionic gonadotropin (HCG) is a glycoprotein secreted by placental trophoblast cells in pregnancy. HCG is a heterodimer composed of two different α- and β-subunits, with the latter being unique to HCG. As well as being the most important diagnostic markers for pregnancy, HCG is also a tumor marker, therefore, quantitative detection of HCG is of great value. Numerous advanced technologies have been developed for HCG concentration detection including electrochemical immunoassay, chemilumin…
-
50.
Hyperglycosylated hCG (hCG-H) is an over-glycosylated variant of hCG. While regular hCG is produced by differentiated syncytotrophoblast cells, hCG-H is independently secreted by stem cytotrophoblast cells. hCG-H has an independent function to regular hCG. It is the direct promoter of trophoblast invasion and malignancy. Invasion as in implantation of pregnancy and malignancy as in choriocarcinoma. Neither will occur in the absence of hCG-H. hCG-H measurements have multiple functions. Primarily…
-
51.
hCG is a glycoprotein hormone composed of two dissimilar subunits. This hormone is not only heterogeneous in peptide structure but also in combination of subunits and carbohydrate structure. Common hCG-related molecules include hCG, hyperglycosylated hCG, nicked hCG, hCG missing the beta-subunit C-terminal peptide, free alpha-subunit, free beta-subunit, nicked free b-subunit and urine beta-core fragment. This article discusses the structures these hCG-related molecules and their occurrences in e…
-
52.
Luteinizing hormone (LH) and its homologue, human chorionic gonadotropin (hCG), are able to elicit multiple effects in the central nervous system (CNS) through binding to their receptors. Specific receptors for LH/hCG have been identified in the hippocampus, dentate gyrus, hypothalamus, cortex, brain stem, area postrema, cerebellum, choroid plexus, ependymal cells, glial cells, neural retina, pituitary gland, and neuron processes of the spinal cord. Neurotropic effects of LH and hCG have been de…
-
53.
We have produced transgenic (TG) mice expressing under the ubiquitin C promoter either the glycoprotein hormone common alpha-subunit (C(alpha)) or human chorionic gonadotropin (hCG) beta-subunit. C(alpha) overexpression alone had no phenotypic effect, but the hCG(beta) expressing females, presenting with moderately elevated levels of bioactive LH/hCG, due to dimerization of the TG hCG(beta) with endogenous C(alpha), developed multiple gonadal and extragonadal neoplasias. Crosses of the C(alpha)…
-
54.
To review contemporary knowledge of the hCG molecule, its isoforms and the importance of glycosylation. Biologic variants and glycoforms of hCG have different biological activities and functions related to the control of menstrual cycle, conception, gestation as well as gynaecologic and non-gynaecologic malignancies. A review. Department of Obstetrics and Gynaecology, University Hospital Olomouc. To present own experience and an overview of recent literature in molecular biology, clinical bioche…
-
55.
When considering human chorionic gonadotropin (hCG) and hCG tests, it is important to realize that it is not a single biological molecule. The regular form of hCG produced by differentiated syncytotrophoblast cells (regular hCG) is a hormone made with the primary function of maintaining the myometrial and decidual spiral arteries and the vascular supply of the placenta during the full course of pregnancy. Hyperglycosylated hCG (hCG with double-size O-linked oligosaccharides) is made by undiffere…
-
56.
HCG is composed of two subunits, HCGalpha and HCGbeta. During early pregnancy, HCG stimulates progesterone production in the corpus luteum, and injection of HCG is widely used to induce ovulation in assisted reproduction treatment (ART). Under experimental conditions, the free subunits have been shown to exert functions other than those of HCG, but the relevance of these remains to be determined. Intact HCG, free subunits and degraded forms of these occur in biological fluids, and determinations…
-
57.
Recent evidence suggests that human chorionic gonadotropin (hCG), in addition to its well-known endocrine effects on the corpus luteum, may act as a growth and differentiation factor during pregnancy. According to experimental results, its mode of action may be divided into three sequential phases. During the first phase, which begins at the blastocyst stage and lasts until the occurrence in the serum, hCG acts preferentially in a juxtacrine manner. We have used an intrauterine microdialysis sys…
-
58.
Luteinizing hormone (LH) and human chorionic gonadotropin (hCG) share a common receptor. LH/hCG receptors, located in the vascular smooth muscle and endothelial cells of uterine blood vessels, are most numerous in smaller intramyometrial vessels and are cyclic in nature. There is a correlation between hCG levels and decreased uterine vascular resistance in humans, and in pseudopregnant rats, hCG decreases uterine blood flow. We found that systemic administration of hCG to cycling rats reduced ut…
-
59.
To compare the potential value of maternal serum total hCG and free beta-hCG in predicting the risk for fetal trisomies during the first trimester of pregnancy and to examine whether data on maternal hCG and fetal nuchal translucency thickness can be combined to derive risks. Maternal serum total hCG and free beta-hCG were measured in samples from 83 singleton pregnancies with fetal chromosomal abnormalities (trisomy 21 (n = 41), trisomy 18 (n = 19), trisomy 13 (n = 8) sex chromosome aneuploidie…
-
60.
The pregnancy hormone human chorionic gonadotropin (hCG) is also present at low concentrations in plasma and urine of men and nonpregnant women. hCG immunoreactivity occurs in various molecular forms: Besides the intact hCG heterodimer, considerable amounts of proteolytically cleaved forms, free subunits, and fragments are found in plasma and urine. Especially in urine, proteolytic fragments constitute a major part of the hCG immunoreactivity. The different forms of hCG cross-react to various de…
-
61.
To examine the structure and metabolism of human chorionic gonadotropin (hCG) and the effect of molecular heterogeneity on the immunodiagnosis and monitoring of gestational trophoblastic disease. A review of the current medical literature concerning measurement of hCG and hCG-related molecules. hCG molecules in gestational trophoblastic disease are more heterogeneous or degraded in serum and urine samples than in normal pregnancy. Appropriate measurement and monitoring of hCG levels in gestation…
-
62.
Human chorionic gonadotropin (hCG) preparations have been widely used as a surrogate for the mid-cycle luteinizing hormone (LH) surge for several decades. The urinary source of hCG preparations was favored for many years because of the easy collection of the starting material. However, the final structure of these urinary-derived preparations appears to be quite different from the natural placenta product. Furthermore, many disadvantages of these commercial preparations have been reported, such…
-
63.
Threatened abortion (TA), vaginal bleeding before 20 weeks in a viable pregnancy, affects 20-25% of early pregnancies. Its unpredictable nature is a major clinical challenge. Current diagnostics (β-hCG and ultrasound) are retrospective and fail to reveal the dynamic pathology. This review presents the "Danger Signal" Hypothesis, focusing on the β-hCG-TNF-α-T cell axis, to explain TA pathogenesis. The process involves three stages: 1) Initiation: Stressed trophoblasts secrete aberrantly glycosyla…
Research Articles
172-
64.
Analysis of the effects of human-derived gonadotropin drugs, FSH and LH (Repronex) and hCG (Novarel), on oocyte maturation, using a porcine oocyte in vitro maturation system as a culture model. Randomized research experimental study. Academic basic research laboratory. Prepubertal gilts that were slaughtered in the local slaughter house. Oocytes will be exposed to immunofluorescent staining and confocal laser scanning microscopy: Western blot analysis on cumulus-oocyte-complexes following treatm…
-
65.
There are 12 types of automated total hCG tests sold today, the Abbott Architect, Abbott AxSym, the Beckman Access 2. Beckman DxI 800, the Ortho Vitros EciQ, Roche Elecsys hCG+β, Siemens ACS180, Siemens Centaur, Siemens Dimension, Siemens Immulite and Siemens Stratus, and the Tosoh A1A. All tests claim to be total hCG tests but do not define what total means. Total hCG test needs to detect all hCG variants in order to be used for all hCG test clinical applications. Here we assess this ability. C…
-
66.
While human chorionic gonadotropin (hCG) appears to have an essential role in early pregnancy, it is controversial whether the hyperglycosylated form of hCG (hCG-h), which is the major hCG isoform during the first 4-5 weeks of pregnancy, is able to activate LH/hCG receptor (LHCGR). To address this, we utilized different extensively characterized hCG and hCGβ reference reagents, cell culture- and urine-derived hCG-h preparations, and an in vitro reporter system for LHCGR activation. The WHO hCG r…
-
67.
Pregnancy tests for human chorionic gonadotrophin (hCG) are used widely in hospital and home settings. Assays measuring hCG also have uses in prenatal screening and oncology. The output from three recent international workshops provides a framework for reliable measurement of hCG. Requirements for future hCG assays include use of clear descriptive nomenclature, informed selection of antibodies of well-defined epitope specificities, and design of robust methods. Tests will be precisely characteri…
-
68.
Human chorionic gonadotropin (hCG) detection is indicative of pregnancy and can be indicative of some forms of cancerous tumors. The hCG drug itself, however, is a performance enhancing substance used by male athletes to increase testosterone production. Antidoping testing for hCG is conducted in urine, often on immunoanalyzer platforms, many of which utilize biotin-streptavidin dependent immunoassays in which the presence of biotin in samples is a known confounding factor. While biotin interfer…
-
69.
We describe a woman with constantly elevated hCG levels in serum. Since assay interference, pregnancy or cancer did not explain the elevated levels, we measured the concentrations of hCG, its β subunit (hCGβ) and its core fragment (hCGβcf) in serum and urine using specific assays, to understand the nature of the elevated hCG levels. We used 3 assays for total hCG (these assays also recognize hCGβ and to various degrees hCGβcf), 3 for intact hCG heterodimer, 3 for free hCGβ and one for hCGβcf. Wi…
-
70.
We have shown that most patients with seminomas have elevated serum concentrations of the free β subunit of human chorionic gonadotropin (hCGβ) and that in nonseminomatous testicular cancer, most of the hCG in the serum is hyperglycosylated (hCG-h). However, the tissue expression of hCG-h or hCGβ in germ cell tumors (GCTs) has not been reported. Our objective was to study the expression and diagnostic value of hCG-h and hCGβ in testicular GCTs. We studied the immunohistochemical expression of hC…
-
71.
Measuring serum and cerebrospinal fluid human chorionic gonadotropin (hCG) is essential for the diagnosis of intracranial germ cell tumors. There are three types of hCG-related markers in clinical use: hCGβ, intact hCG, and total hCG. The best marker for the diagnosis of intracranial germ cell tumors, especially germinoma, is currently unknown. This study aimed to evaluate the usefulness of these hCG-related markers. We investigated 19 serum samples obtained from 6 patients with histologically d…
-
72.
Recent evidence from the literature suggested that hCG preparations purified from urine of pregnant women, which are widely used in in vitro studies and IVF programs, may contain contaminants such as EGF. To determine the putative biological effects of the contaminating growth factor, we here investigated distinct trophoblast differentiation processes in the presence of various hCG compounds. Western blot analyses indicated that treatment of trophoblastic SGHPL-5 cells and purified term trophobl…
-
73.
To examine the properties of the unique degraded forms of hCG produced in familial hCG syndrome and to describe 15 cases referred to the USA hCG Reference Service. Total hCG was detected by Immulite total hCG assay. The molecules missing the beta-subunit C-terminal peptide were detected by the Centaur total hCG assay; the proportion of molecules missing the beta-subunit C-terminal peptide was determined as Immu-lite assay minus Centaur assay. Free beta-subunit was detected in the FBT11 free beta…
-
74.
Insights into the hyperglycosylation of human chorionic gonadotropin revealed by glycomics analysis.
Human chorionic gonadotropin (hCG) is a glycoprotein hormone that is essential for the maintenance of pregnancy. Glycosylation of hCG is known to be essential for its biological activity. "Hyperglycosylated" variants secreted during early pregnancy have been proposed to be involved in initial implantation of the embryo and as a potential diagnostic marker for gestational diseases. However, what constitutes "hyperglycosylation" is not yet fully understood. In this study, we perform comparative N-…
-
75.
Gonadotropins are a class of heavily glycosylated protein hormones, thus extremely challenging to characterize by mass spectrometry. As biopharmaceuticals, gonadotropins are prescribed for the treatment of infertility and are derived from different sources: either from pooled urine of pregnant women or upon production in genetically modified Chinese Hamster Ovary cells. Human chorionic gonadotropin (hCG) is sold as a biopharmaceutical under the name Pregnyl® (urinary hCG, u-hCG) and Ovitrelle® (…
-
76.
Recently, several LH/human chorionic gonadotropin (hCG) receptor-independent activities for hCG have been described, including activation of the TGF-β receptor (TGFβR) by hyperglycosylated hCG and stimulation of trophoblast invasion. Because the hCG concentrations used in these studies have been rather high, reflecting physiological hCG levels in pregnancy, even a minor contamination with growth factors, which act at very low concentrations, may be significant. Several commercial hCG preparation…
-
77.
To investigate 405 cases of persistent low concentrations of human chorionic gonadotropin (hCG). The USA hCG Reference Service measured total regular hCG, follicle stimulating hormone and luteinizing hormone (LH) with the Siemens (New York, New York) Immulite 1000 assay. Hyperglycosylated hCG, nicked hCG, C-terminal peptide total hCG, intact regular hCG, free beta-subunit and beta-core fragment were measured in manual microtiter plate assays. Four cases of inherited hCG were identified, with sim…
-
78.
The USA hCG Reference Service has been dealing with cases of persistent low levels of hCG and gestational trophoblastic diseases for 10years. Here we present the complete experience. Total hCG in serum and urine was measured using the Siemen's Immulite 1000 assay. Hyperglycosylated hCG, nicked hCG, free ss-subunit and ss-core fragment were measured using microtiterplate assays with antibodies B152, B151, FBT11 and B210, respectively. The USA hCG Reference Service has identified 83 cases of false…
-
79.
Discordance has been reported in human chorionic gonadotropin (hCG) concentrations measured by different immunoassay kits. We examined the results for 40 serum samples assayed with 10 different hCG immunoassay kits. Results varied considerably. Individual sample results varied by as much as 58-fold. Average results for different kits varied by as much as 1.4-fold for pregnancy (20 samples) and 2.2-fold for trophoblast disease (20 samples) serum. We investigated the causes of this discordance. hC…
-
80.
The role that hCG might play in the oncogenic process in cancer is certainly complex. We know that the expression of hCG and its beta subunit is a widespread phenomenon which has been described in many cancer subtypes. However, hCG's involvement in breast cancer has been antithetical: the detection of ectopically expressed hCG(β) by breast tumors has been employed as a biomarker of malignancy, and hCG has been proposed as a ligand vehicle for toxic drugs, with the aim of targeting the LH/hCG rec…
-
81.
This study evaluated the effect of hCG administration by different routes on D7 (D0=estrus onset) on serum concentrations of hCG and progesterone (P4). Its role in the induction of accessory corpora lutea (aCL), total luteal area (TLA), and vascular area (VA) was assessed by ultrasonography (US). Forty-four goats had estrus induced with intravaginal sponges (60 mg of MAP, six days) plus 200 IU recombinant eCG and 131.5 μg cloprostenol via intramuscular (i.m.) 24 h before sponge removal. Goats re…
-
82.
Luteinizing hormone (LH) and human chorionic gonadotropin (HCG) target their receptor in gonadal and nongonadal cells to stimulate steroidogenesis and cell growth. The aim of the present study was to investigate the expression of HCG/LH-R in endometriosis to elucidate a possible impact of LH and HCG on this disease. Analysis of HCG/LH-R protein expression in 23 paired samples of ectopic and eutopic tissue of cycling women with endometriosis and in endometrial samples from 22 healthy controls was…
-
83.
Human chorionic gonadotropin (hCG) is a pregnancy biomarker, and five forms of this hormone are involved in female physiological regulation. β-core fragment hCG (bcf-hCG) is a fragment of hCG whose biological role in female reproduction has not been completely elucidated. This study aimed to investigate its role in embryo implantation and maintenance of a pregnancy-supportive environment. We analyzed the protein expression pattern of bcf-hCG in the intrauterine environment during early pregnancy…
-
84.
Human chorionic gonadotropin (hCG) is the major pregnancy glycoprotein hormone whose maternal concentration and glycan structure change all along pregnancy. hCG is mainly secreted by the syncytiotrophoblast covering the chorionic villi, but little is known about the source of hyperglycosylated hCG (hCG-H) production. The objective of the study was to analyze expression and secretion of hCG and hCG-H in vitro during human trophoblastic cell differentiation, in situ in first-trimester placentas, a…
- 85.
-
86.
Preoperatively, it is difficult to differentiate between parathyroid cancer (PtCa) and severe primary hyperparathyroidism (PHPT) due to a benign tumor. Human chorionic gonadotropin (hCG) is a tumor marker in trophoblastic and nontrophoblastic cancers and hyperglycosylated hCG is increased in hCG-secreting malignancies. We investigated whether hCG can distinguish PtCa cancer from benign disease and add prognostic information. Observational study. Measurement of urinary hCG (total and malignant is…
-
87.
The applicability of a mass spectrometry (MS)-based method for determination of various forms of human chorionic gonadotropin (hCG) in doping analysis was demonstrated. A clinical study involving the hCG-containing pharmaceuticals Pregnyl and Ovitrelle was carried out, comprising a single injection of one pharmaceutical per participant to a total of 24 healthy male voluntaries. Hereafter, serum and urine samples were collected over a period of 14 days. The analysis of the samples using immuno-MS…
-
88.
The present study was undertaken to investigate whether human chorionic gonadotropin (hCG) beta-core fragment (hCG beta cf) was directly produced by gestational trophoblastic tumors. Immunoreactivity of hCG beta cf was demonstrated in the extracts as well as in the culture media of hydatidiform mole tissues. It was also present in the extracts of choriocarcinoma tissues, and its molar concentration exceeded that of intact hCG. The presence of hCG beta cf was then confirmed by gel chromatography…
-
89.
Pregnyl (hCG), a preparation of human chorionic gonadotropin, was evaluated for its effects on the endocrinological, biochemical and genotoxic changes in female Swiss albino mice. hCG treatment at different doses (25, 50 and 100 I.U./Kg/day) for 5 days was found to significantly increase the plasma levels of hCG, estradiol and progesterone in a dose-dependent manner, while the concentrations of LH and FSH remained below the detection levels. The plasma levels of ALT, CK-MB, creatinine and urea w…
-
90.
Hyperglycosylated human chorionic gonadotrophin (hCG) is an hCG variant with extra-large O-linked oligosaccharides, produced by phenotypically invasive cytotrophoblast cells in choriocarcinoma and pregnancy. It is the principal form of hCG produced in the first weeks of gestation. We investigated the importance of hyperglycosylated hCG in pregnancy testing and its detection by current hCG tests. We measured the concentration of hyperglycosylated hCG and total hCG in 512 pregnancies throughout ge…
-
91.
Prior methods for macaque in vitro fertilization (IVF) have incorporated laparoscopy and/or laparotomy as the primary means for oocyte recovery. Sonographic techniques, as used with human IVF, have been applied to the macaque, both for monitoring the response to hyperstimulation and for follicular aspiration prior to ovulation. Pergonal (hMG) was administered for 7 or 8 days beginning on cycle day 1 or 2 or for 6 days beginning on cycle day 3. This was followed by Pregnyl (hCG) prior to follicul…
-
92.
The objective of this study was to determine the effect of additional human chorionic gonadotrophin (hCG) on the ovarian response of gilts previously treated with 200 IU hCG combined with 400 IU equine chorionic gonadotrophin (eCG) (eCG/hCG). Seventy-one prepuberal gilts (105 ± 7.5 kg) were assigned to groups: i) eCG/hCG (hCG-0; n = 25); ii) eCG/hCG followed by 100 IU of hCG at 24 h (hCG-100; n = 24); iii) eCG/hCG followed by 200 IU hCG at 24 h (hCG-200; n = 10); and iv) controls (CON; n = 12).…
-
93.
This retrospective study assessed treatment preferences and outcome with testosterone or HCG / HCG-FSH combination in Indian male idiopathic hypogonadotropic hypogonadism (IHH) subjects (n = 31) above 18 years of age. 38.7% of IHH study subjects had no fertility plans and chose 3 monthly intramuscular testosterone undecanoate. 73.7% of subjects with fertility plans chose human chorionic gonadotropin (HCG) alone due to cost considerations. Spermatogenesis occurred in 21.4% on HCG alone and 60% of…
-
94.
Thyrotropic activity (TSH), measured by the McKenzie mouse bioassay, has been correlated with human chorionic gonadotropin (hCG) activity, measured by radioimmunoassay, in serum and tissue samples from 11 patients with hydatidiform mole and in partially and highly purified preparations of urinary hCG. Serum samples, taken at various times before and after removal of the moles, gave a ratio of 0.42 plus or minus 0.24 muU TSH/U hCG (mean plus or minus SD) (N)=43). In all cases where hCG activity f…
-
95.
Hyperglycosylated human chorionic gonadotropin (hCG-h) contains larger and more complex carbohydrate chains than regular human chorionic gonadotropin (hCG). hCG-h is thought to be the major form of hCG produced by testicular cancers and it has been suggested to play a key role in tumor invasion, but studies on hCG-h in testicular cancer are limited. We studied whether serum hCG is hyperglycosylated, and whether measurement of hCG-h in serum offers clinical value in the management of testicular c…
-
96.
Hyperglycosylated human chorionic gonadotropin (hCG) is a variant of hCG with large oligosaccharide side chains. Although hCG is produced by syncytiotrophoblast cells, hyperglycosylated hCG marks cytotrophoblast cell. Hyperglycosylated hCG signals placental implantation. Total hCG in serum and urine is measured by the Siemens Immulite hCG pregnancy test; the result is in milli-international unit per milliliter. Hyperglycosylated hCG is determined by the B152 microtiter plate assay; the result is…
-
97.
To compare clinical and embryological characteristics in donor cycles triggered for final oocytes maturation with Pregnyl 10 000 IU i.m. versus triptorelin 0.2 mg s.c. in the same patients in two sequential stimulation cycles. The aim of the study is to decrease the risk of the development of ovarian hyperstimulation syndrome (OHSS) at high response donors by the replacement of Pregnyl 10 000 IU i.m. vs. triptorelin 0.2 mg s.c. The administration of a single dose of gonadotropin-releasing hormon…
-
98.
To determine whether circulating hyperglycosylated human chorionic gonadotropin (hCG-H), a promoter of choriocarcinoma growth and tumorigenesis, is a reliable marker of active gestational trophoblastic neoplasia (GTN) or choriocarcinoma, and whether hCG-H can consistently discriminate quiescent gestational trophoblastic disease (GTD) from neoplasia. Patients were those referred to the USA hCG Reference Service for consultation. These included a total of 82 women with GTN, including 30 with histo…
-
99.
Employing a monoclonal antibody (B152) specific for a carbohydrate epitope found on a choriocarcinoma derived hCG, it was discovered that a similar hCG isoform is expressed during early pregnancy. This form differs from later pregnancy hCG in carbohydrate moieties. Profiling of these two hCG isoforms throughout pregnancy utilized two IRMA's: B152-B207 ("hyperglycosylated hCG"-specific assay) and B109-B108 (an IRMA for standard intact hCG isoforms in the WHO hCG reference preparation). The WHO hC…
-
100.
Phantom hCG and phantom choriocarcinoma syndrome (pseudohypergonadotropinemia) refers to persistent mild elevations of hCG, leading physicians to treat patients with cytotoxic chemotherapy for choriocarcinoma when in reality no true hCG or trophoblast disease is present. We report here three cases of the phantom hCG and phantom choriocarcinoma syndrome referred to the hCG Reference Service. In the first case, low levels of hCG were detected in serum (49 to 89 IU/liter) 11 months after the patien…
-
101.
Is measurement of hyperglycosylated HCG (hHCG) superior to beta-HCG (HCG+β) for early pregnancy detection after IVF and embryo transfer? Blood samples were collected on day 4 (+1), 7 (+1) and 11 (+2) after embryo transfer from women aged 18-45 years undergoing first or second fresh or frozen IVF embryo transfer cycles. Biochemical pregnancy was assessed on-site by HCG determination on day 11; clinical pregnancy was assessed by ultrasound on day 21 (+4/-3). Serum hHCG (immunochemiluminometric ass…
-
102.
Anti-doping laboratories routinely use immunoassays to measure urinary concentrations of human chorionic gonadotropin (hCG). To minimize immunoassay differences and false positive screen results from inactive isoforms (free β-subunit (hCGβ), β-subunit core fragment (hCGβcf)) laboratories now use intact hCG instead of total hCG immunoassays to measure hCG. To determine the distribution of hCG isoforms in urine, we determined the concentrations of intact hCG, hCGβ, and hCGβcf in male urine samples…
-
103.
The purpose of this study was to examine the effect of chronic daily hCG treatment on interstitial cell function in the rat, as judged by plasma testosterone levels, the testicular binding of labeled hCG, and the capacity of the testis to respond to gonadotropin stimulation by the production of testosterone in vitro. TWenty-four hours after the first injection of 100 IU hCG there was a significant decline in hCG binding to testis homogenates and an inability to respond to hCG stimulation in vitr…
-
104.
We have recently introduced 125I-hCG as an elimination marker in patients with human chorionic gonadotrophin (hCG) producing testicular cancer. 125I-hCG is a well-known reagent in clinical biochemistry and is used extensively in hCG assays. Previous studies have shown that the iodination process leaves the hCG molecule mainly intact. The iodination, purification and stability of 125I-hCG tracer are described. The aim of the present study was to determine whether or not 125I is associated with hC…
-
105.
In the present work, the first characterizations by Capillary Electrophoresis of the human Chorionic Gonadotropin (hCG) hormone at the intact level were carried out. hCG is a hetero-dimeric glycoprotein, specific to the human pregnancy, consisting of an α and a β subunit, so-called hCGα and hCGβ, respectively. hCG has 8 potential glycosylation sites leading to a high number of isoforms (including glycoforms and other post-translational modifications) that we are interesting to characterize. Firs…
-
106.
To investigate factors predicting postmolar gestational trophoblastic neoplasia (GTN) by combined analysis of clinical features, human chorionic gonadotropin (hCG) value, and hCG ratios. This retrospective study enrolled patients with histopathologically proven molar pregnancy. Patients lost to follow-up before remission or developing postmolar GTN were excluded. Demographic and clinical characteristics and hCG data obtained before and after molar evacuation were collected. Area under the receiv…
-
107.
The current studies were designed to ascertain the fate of hCG bound to rat corpora luteal cell receptors. Graded doses of highly purified hCG (CR119), ranging from 0.1-10.1 micrograms, were injected. Groups of pseudopregnant rats received iodinated hCG, unlabeled hCG, or both. Supraphysiological levels of hCG were used to enhance the internalization of hCG and its receptors. When ovarian membrane pellets (48,000 X g) were subjected to continuous sucrose density ultracentrifugation, two differen…
-
108.
After administration of hCG, hormone enters pseudopregnant rat ovarian cells rapidly. Although evidence for small amounts of hCG bound to receptor exists within cells, the major fraction of internalized hCG is free and not receptor bound. The intracellular site of dissociation of hCG from its receptor is unknown. With internalization the hCG molecule is altered so that most of the hormone will no longer bind to concanavalin A. No free hCG alpha or hCG beta was observed for up to 24 hours after i…
-
109.
The measurement of human chorionic gonadotropin (hCG) in cerebrospinal fluid (CSF) is important for the diagnosis of intracranial or intraspinal trophoblastic tumours. The current study was performed to establish reference values for hCG in CSF and to explore the relationship of CSF hCG and serum hCG in patients who are not pregnant or do not have trophoblastic tumours. CSF samples were obtained from 369 inpatients admitted because of various neurological diseases, excluding pregnancy, trophobla…
-
110.
Human chorionic gonadotropin (hCG) is suggested to regulate placental angiogenesis, however, its role is incompletely understood. hCG may directly stimulate angiogenesis or influence the effect of other angiogenic factors. We examined the effect of hCG and the interplay of hCG with basic fibroblast growth factor (bFGF) and with various adipokines on proliferation of vascular endothelial cells in vitro. Human umbilical vein endothelial cells (HUVEC) were incubated for 2 days with combinations of…
-
111.
Human myometrium contains receptors for hCG/human LH (hLH). This suggested the possibility that hCG and hLH might regulate human myometrium, which has not previously been considered a direct target of gonadotropin regulation. To investigate such a possibility, highly pure and viable smooth muscle cells were isolated from nonpregnant human myometrium and cultured as monolayers. The cells contained hCG/LH receptor mRNA transcripts and a 50-kDa immunoreactive protein that can bind 125I-hCG in a lig…
-
112.
To investigate the capacity of the human corpus luteum (CL) of pregnancy to form cyclic adenosine-3',5'-monophosphate (cAMP) and P in vitro in response to hCG and prostaglandin (PG) E2. Six women undergoing sterilization concomitant with legal abortion and eight women undergoing surgery for ectopic pregnancy were included. Human chorionic gonadotropin was analyzed preoperatively in two serum samples. The CL were excised and luteal specimens were incubated for 2 hours in the presence or absence o…
-
113.
The present study investigated the role of β-hCG in predicting reproductive outcomes and established optimal β-hCG cutoff values in women undergoing cleavage embryo transfer. The patients were transferred with fresh or frozen-thawed embryos and had serum β-hCG levels tested on the 14th day post-embryo transfer. Serum β-hCG levels were compared between different groups. Different cutoff values of β-hCG were established and used to divide the patients into different groups. Reproductive outcomes b…
-
114.
After binding to rat testicular or ovarian luteinizing hormone (LH) receptors, human chorionic gonadotropin (hCG) and mammalian LH can be detected with monoclonal antibodies directed against a conserved epitope on the beta subunit of the hormones. Two such anti-hCG/anti-LH monoclonal antibodies, known as B105 and B110, compete with one another for binding to this epitope region on free and receptor-bound hormone. By comparing the affinities of B105 and B110 for these two forms of hCG, we have de…
-
115.
Human CG (hCG) is the hormone associated with the maintenance of pregnancy. Although three related glycoprotein hormones, LH, hFSH, and hTSH, are secreted by the pituitary, HCG is the only one of this family of glycoprotein hormones that is produced by the placenta in primates to maintain the steroid hormone secretions of the corpus luteum. Although hCG is not considered to be a pituitary hormone, hCG-like immunoreactive materials have been reported in pituitary tissue, blood, and urine from hea…
-
116.
The pharmacological suppression of luteinising hormone or human chorionic gonadotropin (hCG) can reduce Aβ plaques in the brains of rats and mice, but the effects of hCG on the phosphorylated tau protein level in the hippocampus have not been studied. Therefore, we investigated the effects of hCG on the phosphorylated tau protein level and its effect on hCG receptor-immunoreactive neuron density in the hippocampus of Alzheimer's disease (AD) model rats (streptozotocin [STZ] injected intracerebro…
-
117.
The literature shows that hyperglycosylated hCG is the invasion stimulus in malignant gestational trophoblastic diseases. The USA hCG Reference Service has characterized 2 gestational trophoblastic disease conditions marked by low proportion of hyperglycosylated hCG. These are quiescent gestational trophoblastic disease, defined as inactive or benign invasive disease, and minimally invasive gestational trophoblastic disease, defined as slow growing or chemorefractory disease with hCG increasing…
-
118.
A total of 100 Kangal sheep were divided into four groups with the aim of investigating the effectiveness of resynchronization during anestrus for the first time in the literature. The groups were then divided into two further subgroups, namely the resynchronization subgroup group (hCG+resynch) and group (resynch)) and the no resynchronization subgroup (Group (hCG) and group (control)). All the groups started with progesterone-containing sponge insertion on Day 7. The sponge was removed after 7…
-
119.
Human chorionic gonadotropin (hCG) levels were measured in the sera of 443 pregnant women by the beta-hCG radioimmunoassay in order to determine if the third-trimester secondary peak in hCG levels observed by less specific immunoassays was due to cross-reacting substances. hCG was detected as early as six days after presumed conception and peaked between 56 and 68 days, with a nadir at 18 weeks. No secondary rise in hCG levels was demonstrated, indicating that the nonspecific hCG immunoassays gi…
-
120.
The nature of the substance with thyroid-stimulating activity (TSA) present in human chorionic gonadotropin (hCG) prepared from pregnancy urine was investigated. In the mouse thyrotropin bioassay, the characteristic maximum of blood radioactivity obtained with the TSA in hCG preparations occurred after that obtained with pituitary thyrotropin (hTSH) but before that obtained with long-acting thyroid stimulator. Antiserum to the alpha subunit of hCG produced significant neutralization of the TSA i…
-
121.
The present studies were undertaken to delineate the role of sialic acid residues in the two subunits of hCG in relation to its hormonal activity. Sialic acid was removed by treatment of the individual subunits or intact hCG with insolubilized neuraminidase. Desialylated variants of hCG were obtained by combining an asialo subunit (as alpha or as beta) with its complementary intact or desialylated subunit. When tested in the hCG receptor assay using a rat testis fraction, none of the hCG variant…
-
122.
The effects of high density and low density lipoproteins (HDL and LDL) on testosterone synthesis by Leydig cells from rats treated three days earlier with 50 IU human chorionic gonadotropin (hCG) or from saline-injected control rats were investigated. HDL caused a significant, dose-dependent increase in both basal and hCG-stimulated testosterone production by Leydig cells from hCG-treated rats, but had no marked effect on Leydig cells from control rats. The serum testosterone concentration of hC…
-
123.
Results on sera and calibrators vary 1.4- to 2.3-fold among commercial human chorionic gonadotropin (hCG) assays. The relative contributions of calibrators, standards, hCG charge isoforms, and major structural variants to this variation have not been quantified. Purified hCG was separated by isoelectric focusing into four fractions with pI ranges of 3-4, 4-5, 5-6, and 6-7. These four fractions together with pure hCG, hyperglycosylated hCG, hCG beta-subunit (hCGb), nicked hCG, and hCGb core fragm…
-
124.
Ovarian hyperstimulation syndrome (OHSS) is a complication of in vitro fertilization associated with physiological changes after hCG administration to induce final oocyte maturation. It presents as widespread increases in vascular permeability and, in rare cases, results in cycle cancellation, multi-organ dysfunction, and pregnancy termination. These physiological changes are due primarily to activation of the vascular endothelial growth factor (VEGF) system in response to exogenous human chorio…
-
125.
To evaluate the impact of estradiol levels of hCG day (E2-hCG) on pregnancy outcomes in fresh embryo transfer (ET) cycles following antagonist protocol. The retrospective study includes 3192 fresh ET cycles under antagonist protocol at Xiangya Hospital from October 2020 to July 2024. We evaluated the association of E2-hCG and pregnancy outcomes by generalized additive models adjusted for confounders. The turning point of E2-hCG is detected by segmentation regression. Pregnancy outcomes were comp…
-
126.
What is the effect of embryo morphology score on 14-day β-HCG levels and 14-18-day β-HCG doubling values, and do they have differences in day-3 embryo or day-5 blastocyst transfers? Retrospective analysis of 4434 fresh cycles of single embryo transfers (SET) with β-HCG ≥15 mIU/ml on day 14 after transfer via IVF and ICSI. The correlation between embryo morphology score and 14-day β-HCG was examined. Doubling of 14-18 day β-HCG was analysed in 2628 cycles to determine correlations with embryo mor…
-
127.
Chemical deglycosylation of human chorionic gonadotropin (hCG) produced an antagonist (DG-hCG) that specifically bound to hCG receptors but was no longer able to stimulate adenylate cyclase in the murine Leydig tumor cell line, MLTC-1. DG-hCG was restored to an agonist by incubating cells or membranes having the bound analogue with antibodies against hCG (anti-hCG). In the presence of anti-hCG, cyclic AMP accumulation and adenylate cyclase activity were stimulated over DG-hCG alone. There was no…
-
128.
We have studied the concentrations of intact human choriogonadotropin (hCG) and the free hCG beta-subunit in blood samples from singleton pregnancies at risk for habitual or threatened abortion. The samples were obtained weekly between the 6th and 12th weeks and in the 14th and 16th weeks of gestational age. The concentrations of intact hCG, of the free hCG beta-subunit, and of "total" hCG (i.e., intact hCG and the free hCG beta-subunit: hCG + beta) were measured in serum by specific immunoassay…
-
129.
Serum human chorionic gonadotrophin (HCG) concentration is nearly always used to predict pregnancy but there is little data on the clinical utility of the ratio of HCG(21)/HCG(14) combined with double measurement of serum HCG. A total of 1762 cycles were retrospectively analysed for serum HCG concentration and ratio of HCG(21)/HCG(14) on days 14 and 21 after embryo transfer to determine whether the ratio combined with concentration is the optimal predictor of pregnancy. The medians of HCG concen…
-
130.
The DoT and CaSki human cervical carcinoma cell lines ectopically produce material immunologically similar to the beta-subunit of human chorionic gonadotropin (hCG beta). Culture fluids were analyzed by gel filtration chromatography and radioimmunoassay (RIA) using (a) antiserum directed to conformation-specific (core-directed) determinants not involving the carboxyl-terminal peptide (CTP) in hCG beta purified from urinary hCG (i.e., standard hCG beta) or (b) antiserum directed to the CTP in sta…
-
131.
Several human chorionic gonadotropin (hCG) derivatives have been detected in healthy human subjects, indicating that they may play a role in cell function. These hCG derivatives include deglycosylated hCG, proteolytic digestion products of hCG and free alpha and beta subunits of the hormone. It is well documented that testicular Leydig cells are responsive to luteinising hormone (LH) or its analogue hCG. These hormones have high affinity for LH/hCG receptors on the plasma membrane. We designed f…
-
132.
Few molecules have created so much confusion as the hCG series of molecules. Here we present a comprehensive review of hCG as a tumor marker, of hCG and cancer and modern perspectives on the multiplicity of hCG, and its appropriate use in the management of gynecological malignancies and gestational trophoblastic diseases. The complexity of hCG is better understood. There is regular hCG produced by syncytiotrophoblast cells in pregnancy and by hydatidiform moles. This hormone functions to advance…
-
133.
Human chorionic gonadotropin (hCG) is a pregnancy hormone secreted by the placental synctiotrophoblast cell layer that has been linked to fetal growth and various placental, uterine and fetal functions. In order to investigate the effects of hCG on clinical endpoints, knowledge on reference range (RR) methodology and determinants of gestational hCG levels is crucial. Moreover, a better understanding of gestational hCG physiology can improve current screening programs and future clinical manageme…
-
134.
Our laboratory previously demonstrated that cytotrophoblasts and syncytiotrophoblasts in human placental tissue contain hCG/LH receptors. From this finding, we postulated that one role of hCG might be to promote the differentiation of cytotrophoblasts into syncytiotrophoblasts. To test this postulate, cytotrophoblasts were isolated from human term pregnancy placentas and cultured with and without increasing concentrations of highly purified hCG. The results showed that hCG had a biphasic effect…
-
135.
Exposure of aqueous solutions of native human choriogonadotropin (hCG), asialo-hCG (A-hCG), and chemically deglycosylated hCG (DG-hCG) to heat treatment revealed significant differences in their stability. Solutions of hCG and A-hCG were rapidly inactivated above 50 degrees C. On the other hand, solutions of DG-hCG were comparatively more stable under similar conditions as shown by the retention of significant receptor binding, immunological, and hormonal antagonistic activities. Heated solution…
-
136.
Fetal trisomy 21 is associated with elevated maternal serum hCG and its free beta-subunit (hCG-beta) in vivo, and abnormal placental hCG production and glycosylation in vitro. Other maternal serum markers may also be disrupted in major aneuploidies (T21, T18, T13). We evaluated our aneuploidy screening practices, focusing on hCG-beta and hCG glycoforms, and retrospectively analyzed 55 aneuploidy cases diagnosed over a 2 year period, determining maternal serum hCG glycoforms profiles using 2D-ele…
-
137.
hCG is found in pregnancy urine and in urine from some cancer patients in a variety of forms whose concentrations have clinical importance. Recently, concerns about accurate measurement of these forms have been raised because of the finding that hCG with peptide bond cleavages within the beta-subunit is not recognized by commonly used antibodies. Such nicked forms of hCG are biologically inactive or of very low activity. They are present in normal pregnancy urine and to varying extents in the ur…
-
138.
A panel of mouse monoclonal antibodies (MABs) was produced against human chorionic gonadotropin (HCG) and its isolated beta-subunit (beta-HCG). According to their binding specificities the antibodies could be divided into HCG-specific and cross-reactive MABs. The HCG-specific antibodies reacted with antigenic sites on holo-HCG or holo-HCG and beta-HCG, or exclusively with the non-associated beta-HCG chain. The cross-reactive antibodies reacted with either HCG and luteinizing hormone (LH) or with…
-
139.
Monoclonal antibodies to intact hCG and free beta-subunit of hCG permit the recognition of different individual antigenic sites on the hCG molecule. At least seven different epitopes may be recognized on the native molecule and a further two on the free beta-subunit. These antibodies were used in a mouse Leydig cell bioassay system to compare the degree of inhibition of hCG-induced testosterone production. Two antibodies were particularly potent at inhibiting hCG action, suggesting that they bin…
-
140.
The current study investigated the effect of a single administration of human chorionic gonadotropin hormone (hCG) and its nanoparticles (NPs) on testicular hemodynamics using Doppler ultrasonography, testicular volume, testicular echotexture (PIX), and circulating testosterone and nitric oxide (NO) in pubescent goat bucks during summer months. Fifteen Baladi goats were divided into three groups (5 in each) and subjected to a single intramuscular administration of one ml of physiological saline…
-
141.
The USA uniquely does not use quantitative urine human chorionic gonadotropin (hCG) tests despite being invaluable in pregnancy testing and in monitoring cancer patients. We look at current hCG tests and their detection of the degraded forms of hCG predominant in urine. We examine levels of urinary hCG, its usefulness in pregnancy testing, and advantages of urine testing in false positive hCG cases and cancer cases. hCG assays were blindly evaluated at 10 laboratories running different methodolo…
-
142.
Appropriate glycosylation of gonadotropins is essential for the full expression of their biological activity. In this investigation we have compared the properties of glycosylation deficient human chorionic gonadotropin (hCG) produced by chemical deglycosylation (HF treatment--DG-hCG) or recombinant techniques (site directed mutagenesis). Among the recombinant hCG molecules secreted into the culture medium, the following variants containing selective N-glycosylation deletions at delta alpha 1 or…
-
143.
To determine the optimal hCG dose in a dual hCG/GnRH agonist trigger for comparable pregnancy outcomes to hCG, while maintaining low OHSS rates in good-prognosis patients. This retrospective cohort study included patients aged 18-41 years undergoing IVF or IVF/ICSI with fresh embryo transfer from 2013 to 2024. Patients received either hCG-only (5,000-10,000 IU hCG/250-500 mcg Ovidrel) or dual trigger (1,500-2,000 IU hCG + 2 mg GnRH agonist). A total of 2641 cycles were analyzed (1,939 hCG-only,…
-
144.
While recent evidence indicates that the hCG molecule has intrinsic thyroid-stimulating activity (TSA), it is not clear whether a thyrotropic molecule other than hCG accounts for some of the TSA apparent in the crude or highly purified hCG. To determine if a thyrotropic factor is excluded from crude urinary hCG during purification of hCG, the ratio of interstitial cell-stimulating activity (ICSA) to TSA was determined in the starting material used for hCG preparation as well as in the highly pur…
-
145.
The author present a few years opinion for treatment of patients with vaginal bleeding in first trimester of pregnancy and obstetrical complications with Pregnyl(Organon). The basics factors for inclusion in examination group are pregnant women in early pregnancy complicated with vaginal bleeding, with or not a pain. Overall 34 patients whose be treatment, 31 delivered lived and health child, one patient delivered baby with osteogenesis imperfecta and 2 patients the pregnancy is bracked with spo…
-
146.
The regulation of trophoblast secretion of the placental proteins CG (hCG), placental lactogen (hPL), and pregnancy specific-beta-1-glycoprotein (SP-1) has not been fully elucidated. We therefore studied the secretion of hCG, hCG-beta subunit, hCG-alpha subunit, hPL, and SP-1, both in the basal state and after exposure to 8-bromo-cAMP, during the in vitro differentiation of cytotrophoblasts to syncytiotrophoblasts. Term placental tissue was enzymatically digested and cytotrophoblasts purified by…
- 147.
-
148.
An investigation was conducted to determine the effects of supplementing hCG at mating time on luteal function, conceptus growth, placentation and reproductive performance in TexelxClun Forest ewe lambs. After oestrus synchronisation with progestagen sponges and PMSG ewe lambs were treated either with normal saline (n=102) or 150 IU of hCG (n=105) at mating time. At 25 days after mating 24 animals were slaughtered from each group to determine embryo viability and placental development. hCG signi…
-
149.
We have reported previously that the human choriogonadotropin (hCG) receptors of cultured Leydig tumor cells can be down-regulated with hCG or mouse epidermal growth factor (mEGF) and that such down-regulation results in a loss of the steroidogenic response of the cells to hCG. Exposure of the cells to hCG, but not to mEGF, also resulted in a decrease in steroidogenic responses to cholera toxin and cAMP. The results presented herein show that the hCG-induced loss of steroidogenic response to cAM…
-
150.
Patients with trophoblastic diseases produce ordinary and irregular forms of human chorionic gonadotropin (hCG; e.g., nicked hCG, hCG missing the beta-subunit C-terminal segment, hyperglycosylated hCG, and free beta subunit) that are recognized to differing extents by automated immunometric hCG (or hCG beta) assays. This has led to low or false-negative results and misdiagnosis of persistent disease. False-positive hCG immunoreactivity has also been detected, leading to needless therapy for trop…
-
151.
The concentration of beta-subunit (hCG beta) cannot be exactly quantified by means of competitive immunoassay in the presence of high levels of hCG, e.g. during normal pregnancy. Although the specificity and sensitivity of immunometric assay with mixed monoclonal antibodies was much improved, false positive results of hCG beta can, however, be obtained, if a high concentration of hCG is present in the hCG beta-IRMA (Ozturk et al. 1987). In this study hCG beta was therefore measured by subtractio…
-
152.
Home pregnancy testing devices claim >99% diagnostic accuracy for pregnancy and utility on the first day of the missed menses or earlier. We investigated the forms of human chorionic gonadotropin (hCG) in early pregnancy urines, the diagnostic accuracy claim, and the abilities of 15 devices to detect the different forms of hCG. We measured the concentrations of regular hCG and hyperglycosylated hCG (H-hCG, a large hCG variant) in 592 urines. Fifteen home devices were tested according to manufact…
-
153.
Human chorionic gonadotropin (hCG) is a heterodimeric glycoprotein hormone that exists in multiple forms. Immunoassays commonly used in clinical laboratories measure intact hCG, total beta hCG (intact hCG + hCG free beta-subunit), and/or hCG free beta-subunit. Measurement of serum concentrations of hCG is useful for confirmation and monitoring of pregnancy, diagnosis of trophoblastic diseases and monitoring of the efficacy of treatment, and prenatal screening. Correctly reporting results for the…
-
154.
The mechanism by which hCG increases the rat testicular vascular permeability was studied by injecting the testes with hCG (0.1-100 ng) together with testicular interstitial fluid (150 mul) or with the fluid alone (control) and measuring the uptake of i.v. injected [125I]hCG and the interstitial fluid volume in the testes. Both parameters were already increased with 1 ng of hCG and maxima were seen with 2 ng of hCG. The effect of hCG was not inhibited by injection of a 1000-fold excess of deglyc…
-
155.
One hundred twenty-eight prepubertal boys, ages 1-12 years, were referred to our institute because of uni- or bilateral cryptorchidism. Patients with mobile (retractile) testes were not included in the study. They were treated with human chorionic gonadotrophin (hCG, Pregnyl-Teva) twice weekly for five consecutive weeks by the following doses; 1-4 years (n = 53) - 250 U X 10; 4-7 years (n = 51) - 500 U X 10; 7-12 years (n = 24) - 1000 U X 10;i.m. Plasma testosterone (T) levels were measured befo…
-
156.
Successive dilutions of Pregnyl have been submitted to a radioimmunoassay of SP1. We have observed that Pregnyl cross-reacts with SP1. Chromatography of Pregnyl demonstrates that the contaminating substance is different from native SP1. As its concentration is low, it is however not detected in the serum of patients after the administration of exogenous Pregnyl. SP1 measurement can be helpful in detecting early pregnancies after hCG induction of ovulation.
-
157.
Human chorionic gonadotropin (hCG) is a heterodimeric glycoprotein hormone with considerable molecular heterogeneity. There is uncertainty regarding which hCG variants are detected by different hCG assays. The analytical specificity of 8 hCG assays was investigated. WHO International Reference Reagents for hCG, nicked hCG (hCGn), beta subunit (hCGbeta), nicked beta subunit (hCGbetan), and beta core fragment (hCGbetacf) were individually added to hCG-free human serum. Specimens were analyzed with…
-
158.
We hypothesized that the hCG modulates the expression of IFNT-pathway and ISGs in bovine endometrium during early pregnancy. The aim of the current study is to evaluate the effect of hCG on IFNT-pathway signals and ISGs expression in endometrial cells. For this, 29 non-lactating cross-bread cows were used in the study and submitted to a 9-day fixed-time artificial insemination (FTAI) protocol. The day of the AI was considered Day 0 (D0), and five days (D5) after the FTAI, the cows were allocated…
-
159.
Considerable evidence indicates that one third of early pregnancy failures, spontaneous abortions and biochemical pregnancies, are due to chromosomal abnormalities, and two thirds are due to inappropriate implantation. These findings led us to investigate the role of hyperglycosylated hCG, an important pregnancy implantation signal, in pregnancy failures. We used urinary hCG determinations to evaluate a total of 127 pregnancies on the day of implantation, as marked by a positive urinary hCG. The…
-
160.
Retinoic acid (RA), an active metabolite of vitamin A, is an important mediator of cellular differentiation and has been shown to stimulate human CG (hCG) secretion by JEG-3 choriocarcinoma cells in vitro. In order to determine whether RA stimulates the hCG secretion by other trophoblastic cell lines, we evaluated the effect of RA on hCG, hCG-alpha subunit (hCG-alpha), and progesterone secretion in three choriocarcinoma cell lines: JEG-3, JAR, and BeWo. RA stimulated hCG and hCG-alpha secretion…
-
161.
This study was designed to correlate early pregnancy outcome with serum and trophoblastic culture media levels of hCG, alpha hCG, and the alpha hCG/hCG ratio. Maternal serum was obtained from 104 women with normal gestations (n = 25), ectopic pregnancies (n = 43) and spontaneous abortions (n = 36); trophoblastic tissue was obtained from 10 subjects in each group. The alpha hCG/hCG ratio was abnormally elevated in the serum of 46% of women with abortions and 26% of those with ectopic pregnancies.…
-
162.
Several libraries of monoclonal antibodies have been produced against epitopes that reside on hCG, alpha hCG, and beta hCG. Having characterized them physically, we explored their use in the construction of highly specific and sensitive immunoradiometric assays. There were several important immunochemical considerations with respect to developing assays that accurately detect low levels of free subunits in serum in the presence of high concentrations of the native hormone. These include physical…
-
163.
Production of human chorionic gonadotropin (hCG) by extragonadal tumours is not a rare phenomenon. In the liver, similar results have been reported in hepatoblastomas. The present study was attempted to survey hCG level in serum and hCG-immunoreactivity in primary liver carcinoma in adults. Although hCG was elevated in serum in 2 (22.2%) of 9 autopsied cases with hepatocellular carcinoma (HCC), the hCG-reactivity of carcinoma cells was found in 2 (2.1%) of 95 HCC cases. Carcinoma cells positive…
-
164.
Human choriogonadotropin (hCG) and free hCG-beta values for 934 serum samples from patients with seminomatous or nonseminomatous testicular cancer were measured by highly specific immunoradiometric assays (IRMAS). In non-seminoma samples, hCG and hCG-beta were highly correlated (r = 0.82, P less than 0.001). Of 112 "marker-positive" seminoma samples, only 46 (41.1%) showed both increased hCG and hCG-beta. In 39 cases (34.8%) only hCG-beta and in 27 cases (24.1%) only dimer-hCG was increased. Thi…
-
165.
From May 1979 through December 1988, 146 patients with gestational trophoblastic tumors (71 hydatidiform mole, 3 partial mole, 15 choriocarcinoma and 57 persistent trophoblastic tumors) were studied. A total of 1178 daily urine samples were collected before and/or after treatment, and in the course of follow-up. H93 RIA (an HCG specific assay), H80 RIA (an assay detecting hCG and hLH) and a hCG alpha assay measured levels in the urine specimens. Three hCG declining patterns (pattern D, P and R)…
-
166.
Highly purified human chorionic gonadotropin (hCG) interacts with the thyrotropin (TSH) receptor and stimulates triiodothyronine (T3) secretion, iodide uptake and organification, and cyclic adenosine monophosphate (cAMP) formation in human thyroid follicles. Because of interest in the role of the carbohydrate component in the structure-function relationships of hCG we undertook to deplete hCG of its sialic acid or carbohydrate residues and assess the thyrotropic activity of the carbohydrate-modi…
-
167.
<h4>Abstract</h4>Using a large patient series, we aimed to evaluate, in a high-responder population, the effect of triggering oocyte maturation with human choriogonadotropin (hCG) or with a gonadotropin-releasing hormone agonist (GnRHa). We analyzed data from 683 intended fresh embryo transfer cycles (ETCs) and 534 frozen-thawed embryo transfer (FET) cycles. The rates of ovarian hyperstimulation syndrome (OHSS), and the embryological, clinical, and newborn outcomes were compared. Considering the…
-
168.
<h4>Background</h4>Beta-human chorionic gonadotropin (β-hCG) is commonly used in pregnancy detection and as a tumor marker for reproductive system cancers.<h4>Methods</h4>We report a case of a 51-year-old female with primary malignant giant cell tumor of bone (MGCTB) who developed persistently elevated serum β-hCG levels. Considering the possibility of detection interference, we evaluated pre-analytical factors, laboratory quality control, instrumentation, and personnel-related issues, and perfo…
-
169.
To determine the prognostic value of serum β-human chorionic gonadotropin (β-hCG) for predicting live birth following single euploid frozen-embryo transfer (FET), and to develop and validate a prognostic model (iHOPE) for this purpose. This retrospective cohort study used data from two large fertility practices. The model development cohort included 1581 women with a positive β-hCG test after single euploid FET in the United Arab Emirates between March 2017 and June 2023. The external validation…
-
170.
<h4>Objective</h4>To evaluate live birth outcomes based on initial serum human chorionic gonadotropin (hCG) level following single euploid embryo transfer.<h4>Design</h4>Retrospective cohort study.<h4>Subjects</h4>Single center study that included patients who underwent single euploid embryo transfer with initial positive hCG (>2.5 mIU/mL), measured nine days after transfer. Cycles were grouped by hCG range: Group 1 (hCG 2.5 to <11 mIU/mL), Group 2 (11 to <25), Group 3 (25 to <50), Group 4 (50 t…
-
171.
<h4>Purpose</h4>Multiple protocols exist for the dosing and duration of human chorionic gonadotropin (hCG) and the sampling schedule of the hCG stimulation test. This study analyzes the testosterone response following a single-dose hCG test.<h4>Methods</h4>This observational study analyzes 103 prepubertal undervirilized males who underwent a single-dose hCG test. A dosage of 1,500 IU was used for those under 2 years of age and 5,000 IU for those over. Testosterone levels were measured before and…
-
172.
<h4>Background</h4>Serum beta-human chorionic gonadotropin is routinely measured as a pregnancy marker in women of reproductive age prior to diagnostic and therapeutic interventions. Although a positive result commonly indicates pregnancy, false-positive values may occur, particularly in women with chronic kidney disease due to impaired renal clearance.<h4>Case presentation</h4>We report the case of a 23-year-old Iranian woman with end-stage renal disease on hemodialysis who presented with persi…
-
173.
<h4>Background</h4>The term post-cycle therapy (PCT) often appears in bodybuilding forums in the context of anabolic-androgenic steroids (AAS) cessation. To reduce the negative impact of AAS on the hormonal system, unapproved PCT is used, which consist of medications that help restore hormonal balance. The most used medicinal products are selective estrogen receptor modulators (SERMs), aromatase inhibitors (AIs), and preparations containing human chorionic gonadotropin (hCG). These substances ar…
- 174.
-
175.
<h4>Objective</h4>To evaluate outcomes of delaying intervention until Day 10 in patients with tubal ectopic pregnancy (EP) showing < 15% β-hCG decline between Days 4-7 after single-dose methotrexate (MTX).<h4>Methods</h4>This retrospective cohort included patients treated with single-dose MTX for tubal EP (2014-2022). Those without ≥ 15% β-hCG decline by Day 7 were observed until Day 10 before further treatment. . The primary outcome was resolution with a single MTX dose, without additional medi…
-
176.
<h4>Objectives</h4>To evaluate the association of maternal β-human chorionic gonadotropin (β-hCG), neonatal thyroid hormones including free triiodothyronine (fT3), free thyroxine (fT4), and thyroid-stimulating hormone (TSH), and neonatal serum testosterone with anogenital distance (AGD) in term male and female newborns, and to assess sex-related differences.<h4>Methods</h4>This hospital-based cross-sectional study included 133 term newborns (90 males and 43 females) delivered between 37 and 40 w…
-
177.
Frozen-thawed embryo transfer (FET) in hormone replacement cycles (HRC) is widely used in assisted reproductive technology (ART). However, interpreting early serum human chorionic gonadotropin (hCG) levels remains challenging, especially in the absence of endogenous luteal function. This case report describes a 30-year-old woman who underwent FET with a high-quality blastocyst under HRC. At 4+1 weeks, her serum hCG level was 6.6 mIU/mL ; hormone support was discontinued, assuming a biochemical p…
-
178.
Human chorionic gonadotropin (β-hCG) is a key biomarker for the diagnosis and monitoring of gestational trophoblastic disease (GTD). Current gold standard methods, such as chemiluminescent immunoassays and ELISA, are limited by high operational costs, long analysis times, and the requirements for centralized laboratory facilities, which restrict their accessibility, especially in resource-limited settings. As a promising alternative, electrochemical biosensors offer rapid, sensitive, selective,…
-
179.
Human Chorionic Gonadotropin (hCG) mediates the activation of luteinizing hormone/choriogonadotropin receptor (LHCGR) by binding to it, which is critical for human reproduction. However, specific dynamics of such interaction remain ambiguous. Herein, we utilized single-molecule force spectroscopy (SMFS) to carry out quantitative analysis during the binding between hCG and separate LHCGR domains. Two distinct binding mechanisms were detected within the LHCGR extracellular domain (ECD), associated…
-
180.
<h4>Background</h4>The accuracy of serum human chorionic gonadotropin (hCG) detection is crucial for the diagnosis of gestational and trophoblastic tumors. Rheumatoid factor (RF), as a common autoantibody in patients with rheumatoid arthritis, often leads to interference in immune detection.<h4>Methods</h4>We report a case of using dithiothreitol (DTT) to successfully eliminate the interference of RF to hCG detection.<h4>Results</h4>After DTT pretreatment, serum RF level decreased from 293.5 IU/…
-
181.
<h4>Objective</h4>This study aims to develop a machine learning model for predicting early pregnancy outcomes by combining baseline levels and dynamic changes of β-human chorionic gonadotropin (β-hCG), progesterone (P), and estradiol (E2).<h4>Methods</h4>This retrospective study screened out 421 patients treated at the Lanzhou University Second Hospital between March 2023 and August 2024. Feature selection was performed using Least Absolute Shrinkage and Selection Operator (LASSO) and Random For…
-
182.
In assisted reproductive technology (ART), controlled ovarian hyperstimulation (COS) plays an important role in guiding treatment progress and determining success. Many ovulation-inducing agents are used in this process, including human menopausal gonadotropin (HMG), recombinant follicle-stimulating hormone (r-FSH), recombinant luteinizing hormone (r-hLH), urinary human chorionic gonadotropin (u-hCG), and recombinant human chorionic gonadotropin (r-hCG). HMG, which comes from the urine of postme…
-
183.
<h4>Objective</h4>To describe a rare pediatric case of familial human chorionic gonadotropin (hCG) syndrome presenting with concurrent elevation of beta-hCG (β-hCG) in both blood and cerebrospinal fluid (CSF). This report aims to expand the phenotypic spectrum of this condition and discuss diagnostic challenges to avoid misdiagnosing this benign disorder as an intracranial malignancy.<h4>Methods</h4>Clinical data were collected from the proband, an 8-year-9-month-old girl presenting with central…
- 184.
- 185.
-
186.
We present a case of a woman in her 20s with right iliac fossa pain. Initial investigations showed mildly elevated inflammatory markers and serum beta human chorionic gonadotrophin (hCG) <1 mIU/mL. She was taken to theatres as a presumed early appendicitis but found to have haemoperitoneum with a free-floating cystic structure in the pouch of Douglas with intact pelvic organs. This was subsequently confirmed histologically as a gestational sac which had likely been expelled via the abdominal ost…
- 187.
-
188.
<h4>Introduction</h4>β-Human chorionic gonadotropin (β-hCG) is a pregnancy hormone secreted by the syncytiotrophoblast layer of the placenta. It is related to fetal growth as well as the placenta, uterus, and fetal function. Low β-hCG in early pregnancy is closely associated with pathological pregnancies such as miscarriage, and its mechanism may be related to abnormal development of placental villi. Here we present a 35-year-old pregnant woman who, after natural conception, had low levels of β-…
-
189.
<h4>Introduction</h4>Human chorionic gonadotropin (hCG) is a heterodimeric hormone regulated in part by the maternal neuroendocrine-placenta axis. Serum levels of the beta subunit (hCGβ) are higher in Black vs. White pregnancies. The underlying causes of the difference remain unclear. The objective of the study was to measure associations of maternal demographic and anthropometric characteristics, and self-reported measures of stress and discrimination with hCG and its subunits in a racially div…
-
190.
Ectopic pregnancy is usually associated with detectable serum β-human chorionic gonadotropin levels. A rare case of chronic tubal ectopic pregnancy with undetectable beta human chorionic gonadotrophin (β-HCG) that mimicked a large ovarian endometrioma is reported. A 34-year-old multiparous woman presented with prolonged abnormal uterine bleeding and chronic pelvic pain following a 45-day delay in menstruation. Imaging revealed a large complex left adnexal mass measuring 12 × 10 × 7 cm, highly su…
-
191.
<h4>Introduction</h4>Human chorionic gonadotropin (hCG) and gonadotropin-releasing hormone agonist (GnRHa) are widely used for final maturation of follicles in fertility treatment, yet the detailed dynamics of follicle stimulating hormone (FSH), luteinizing hormone (LH)/hCG and their receptor expression (i.e. FSHR and LHR) during the ovulatory process remain insufficiently characterized.<h4>Material and methods</h4>This prospective, single-center study included 50 women undergoing ovarian stimul…
-
192.
<h4>Background</h4>This study investigated whether triple therapy with human chorionic gonadotropin (hCG), follicle-stimulating hormone(FSH) and testosterone(T) in congenital hypogonadotropic hypogonadism(CHH) promoted more timely virilization, aiding psychosocial development while reducing hCG requirements, offering a balanced approach to long-term management.<h4>Methods</h4>An open-label randomized controlled trial (1:1:1) was conducted in adult males with CHH. Group A received triple therapy,…
-
193.
<h4>Background</h4>Human chorionic gonadotropin (hCG) is a glycoprotein hormone critical for reproduction, particularly in pregnancy maintenance and fertility treatments. Beyond reproduction, hCG may influence immune regulation, cancer biology, and neurological processes.<h4>Objective</h4>This review critically examines the current evidence regarding the potential neurological effects of hCG, synthesizing findings from experimental and clinical studies to assess its proposed roles in neuroinflam…
-
194.
An angular pregnancy is a rare form of ectopic implantation. We report a 30-year-old primigravida presenting with an abnormal beta-human chorionic gonadotropin (b-hCG) trend. At presentation, her b-hCG was 1,950 mIU/mL. Ultrasound showed an angular gestational sac with increased vascularization and deep myometrial extension. Methotrexate was administered, achieving biochemical response but with persistent suspicious ultrasound findings, suggesting ongoing trophoblastic activity. Due to this disc…
-
195.
Case oneA young woman presented to the Early Pregnancy Assessment Unit (EPAU) with abdominal pain, amenorrhoea and variably positive home-pregnancy tests. On review, a point-of-care test (POCT) for urine beta-HCG (β-HCG) was negative but a blood test using the Abbott i-STAT β-HCG POCT device was positive. Initial transvaginal ultrasound did not demonstrate an intra- or extra-uterine pregnancy. Over the following 2 months, weekly plasma POCT iSTAT β-HCG checks remained positive. After a further u…
-
196.
Choriocarcinoma, a rare yet highly aggressive gestational trophoblastic neoplasia, is uniquely responsive to chemotherapy. The serum marker β-human chorionic gonadotropin (βhCG) has long been central to its diagnosis and monitoring, but not without limitations. Persistent false positives, poor specificity for residual disease or resistance, and slow detection of relapse are a few to mention. Advances in precision oncology have introduced novel biomarkers, such as ctDNA, circulating tumor cells (…
- 197.
-
198.
<h4>Background</h4>The GnRH antagonist protocol is widely used in IVF/ICSI treatments. It involves daily injections of a GnRH antagonist starting on stimulation day 5 or later to prevent premature ovulation by suppressing the endogenous gonadotropin surge, continuing until hCG is administered to trigger final follicle maturation. Although the protocol is designed to control the timing of ovulation and prevent spontaneous ovulation, the frequency and impact of an endogenous LH rise occurring betw…
-
199.
The study evaluated the use of hCG at different times in the TAI protocol on the fertility of Bos indicus cows. In Experiment 1, cows received a progesterone device and 2 mg of estradiol benzoate (EB) on D0. The device was removed on D8.5 (study A) or D7 (study B), followed by 500 µg of cloprostenol and 1 mg of EB or estradiol cypionate. At this moment, cows were assigned to Control (no treatment), eCG (300 IU), or hCG (150 IU) groups. TAI occurred 36 h (A) or 48 h (B) post-device removal. In Ex…
-
200.
Physiological human chorionic gonadotropin (hCG) elevations in postmenopausal women are prone to misclassification as pathological. Substantial inter-system variation exists among immunoassays, and system-specific reference intervals (RIs) for this population have not been established. This study aimed to establish 97.5th percentile RIs and 99th percentile thresholds for serum hCG in healthy postmenopausal women across four chemiluminescence immunoassay (CLIA) systems. A total of 460 postmenopau…
-
201.
To assess whether the changing direction of serum β-subunit of human chorionic gonadotropin (β-hCG) after high-intensity focused ultrasound (HIFU) and before ultrasound-guided dilation and curettage (USg-D&C) influences procedural safety and outcome in caesarean scar pregnancy (CSP). This retrospective study was conducted at Deyang People's Hospital, Deyang, China. A total of 210 patients with cesarean scar pregnancy (CSP) were enrolled and divided into two groups based on the direction of serum…
-
202.
Efficient estrus synchronization is important for improving reproductive performance in dairy herds; however, variations in ovarian activity among cows of different parities may influence responses to synchronization protocols. The present study evaluated the effects of pre-synchronization with gonadotropin-releasing hormone (GnRH) or human chorionic gonadotropin (hCG) before the Heat Synch protocol on estrus expression, pregnancy outcomes, and serum progesterone concentrations in Holstein cows…
-
203.
Most available data on human chorionic gonadotropin (hCG) elevations in menopausal women are derived from studies using Roche assays, with limited evidence across other immunoassay platforms. This study aimed to establish assay-specific reference values for hCG and evaluate the impact of age and renal function. In this prospective study, 300 women were divided into five groups (n=60 each): perimenopausal (40-54 years), three postmenopausal age groups (55-69, 70-84, ≥85 years; all with estimated…
-
204.
BackgroundEarly prediction of adverse neonatal outcomes remains challenging. This study evaluated the associations and predictive performance of first-trimester pregnancy-associated plasma protein-A (PAPP-A), free β-human chorionic gonadotropin (β-hCG), nuchal translucency (NT), and maternal age.MethodsThis prospective cohort enrolled 1244 singleton pregnancies at 11-13 + 6 weeks, with 1229 analyzed after 15 were lost to follow-up. Primary outcome comprised preterm birth, low birth weight, or ne…
-
205.
This study aimed to introduce a first-cycle β-hCG response marker for predicting first-line single-agent chemoresistance in low-risk gestational trophoblastic neoplasia (GTN). This retrospective study included 299 patients. Patients were randomly assigned to a development cohort (n = 198) and internal validation cohort (n = 101). The primary exposure was the C2/C1 β-hCG ratio, defined as the serum β-hCG level before cycle 2 divided by the level before cycle 1. Restricted cubic spline and receive…
-
206.
Gonadotropins regulate granulosa-cell function during ovarian follicular development, and extracellular vesicles (EVs) are potential mediators of intercellular communication within the follicle. However, the regulation of EV RNA cargo following gonadotropin stimulation remains incompletely understood. Here, we investigated human chorionic gonadotropin (hCG)-responsive EV RNA profiles using three experimental models: two Lhcgr-expressing clones of a mouse granulosa-cell tumor-derived cell line an…
-
207.
Embryonic loss in cattle is partly attributed to insufficient luteal progesterone (P4) support, and human chorionic gonadotrophin (hCG) administered on Day 5 after insemination is an established strategy to raise P4 by inducing an accessory corpus luteum (CL). Whether this endocrine change alters the conceptus transcriptome beyond interferon-tau (IFNT), and whether such an effect persists into later elongation, remains unclear. This study evaluated whether hCG-induced accessory CL formation and…
-
208.
A 26-year-old patient developed false-positive elevation of human chorionic gonadotropin (hCG) serum levels 2 years after cure from testicular seminoma. The increased levels normalized without any intervention after cessation of oral intake of dietary supplements consisting of creatine, multivitamin pills, and amino acid powder.
-
209.
We investigated whether combining human chorionic gonadotropin (hCG) with ketoprofen after timed artificial insemination (TAI) improves pregnancy rates and explored the underlying mechanisms through serum metabolomics and in vitro endometrial cell analysis. Dairy cows (n = 710) were allocated to three groups: hCG + ketoprofen (1500 IU hCG on day 7 and ketoprofen at 3 mg/kg on days 15-16 of TAI; n = 249), hCG only (1500 IU hCG on day 7 of TAI; n = 246), or control (n = 215). After adjusting for p…
-
210.
To establish gestational day-specific reference values for serum hCG in early pregnancy following embryo transfer and identify maternal and treatment-related factors contributing to its variability. Retrospective, single-center cohort study. Singleton healthy term live births following single embryo transfer, with serum hCG measurements obtained between gestational days 25 and 65. None. Gestational day-specific serum hCG reference values and estimated effects of maternal and treatment characteri…
-
211.
The impact of dominant follicular diameter at hCG trigger on live birth rate (LBR) in modified natural cycle frozen-thawed embryo transfer (mNC-FET) remains unclear. This study aimed to evaluate this relationship and explore whether flexible triggering based on follicle size is acceptable. A retrospective study included 1669 mNC-FET cycles. The cycles were divided according to the dominant follicle diameter on the hCG day: ≥16 mm (n = 1439) and <16 mm (n = 230). The LBR was compared between the…
-
212.
To evaluate the diagnostic performance of the American College of Obstetricians and Gynecologists (ACOG)-recommended β-hCG discriminatory zone (DZ) of 3500 mIU/mL for detecting hallmarks of early intrauterine pregnancy (IUP) and for identifying ectopic pregnancy. To assess how ultrasound findings in the absence of an IUP modify the likelihood of ectopic pregnancy. This study is a retrospective review of same-day quantitative beta-human chorionic gonadotropin (β-hCG) and pelvic US (February 2018–…
-
213.
While serum estradiol (E2) predicts ovarian response and endometrial receptivity, its role in embryonic development remains unclear. This study assessed the association between E2 levels on the day of human chorionic gonadotropin (hCG) trigger and the euploid blastocyst rate (EBR) in preimplantation genetic testing (PGT) cycles. This retrospective study included 3,082 couples who underwent PGT between 2017 and 2022, comprising 18,036 oocytes and 5,009 blastocysts screened using next-generation s…
-
214.
In assisted reproductive technology (ART), the assessment of sex hormones is indispensable. Maintaining an appropriate level of luteinizing hormone (LH) is crucial for ovarian and endometrial development. However, the relationship between LH concentrations on the hCG trigger day and pregnancy outcomes after fresh embryo transfer (ET) remains relatively unclear. The aim of our study was to explore the role of serum LH levels in live birth rates (LBRs) and its specific relationship. We conducted a…
-
215.
Elevated progesterone levels on the day of human chorionic gonadotropin (hCG) trigger are known to adversely affect pregnancy outcomes in fresh embryo transfer (fET) cycles, but their impact on neonatal outcomes remains poorly understood. This study aimed to investigate the association between progesterone levels on hCG trigger day and neonatal outcomes, and to explore the progesterone threshold, so as to provide reference for clinical decision-making. This retrospective cohort study included 2,…
-
216.
To examine the morphological features of cases with immunohistochemical (IHC) expression of beta-human chorionic gonadotropin (β-hCG) in mononuclear seminoma cells (MSC) and to investigate the histopathological and clinical significance of this expression pattern. A total of 76 patients with pure seminoma (without syncytiotrophoblastic giant cells) and at least 1 year of follow-up were included in the study. IHC staining for β-hCG and CD117 (c-KIT) was retrospectively performed. The β-hCG and CD…
-
217.
To identify distinct early beta-human chorionic gonadotropin (β-hCG) trajectories following single-dose methotrexate (MTX) treatment for tubal ectopic pregnancy and to evaluate their associations with treatment outcomes and potential value for Day-7 posttreatment risk stratification. This retrospective cohort study included hemodynamically stable patients with confirmed tubal ectopic pregnancy treated with single-dose MTX. Among 828 patients in the all-clinical cohort, 373 had quantitative β-hCG…
-
218.
This study directly compares hCG and buserelin as ovulation-inducing agents following eCG-based superovulation in weaned donor sows, focusing on their practical impact on ovulation-embryo synchrony under field conditions. Fifty-five multiparous sows received 1000 IU eCG 24 h after weaning and were treated at onset of estrus with either 750 IU hCG or 10 μg BU. Embryos were recovered on Day 6 after estrus. Ovulatory response, embryo recovery, fertilization rate and viable embryo number did not dif…
-
219.
Two of the most used hormones in sport, included in the WADA list of banned molecules, are human chorionic gonadotropin (hCG) and insulin-like growth factor (IGF-I). Male athletes may use pharmaceutical preparations of hCG to stimulate the production of testosterone before competition and IGF-I to stimulate muscle protein synthesis, promote glycogen storage, and improve lipolysis. Dry matrix microsampling and dried blood spots (DBS) are very promising strategies to improve current doping control…
-
220.
Gestational duration is influenced by multiple factors, with placental function being one of the key determinants. First-trimester serum biomarkers reflect the quality of placentation and may be associated with the duration of pregnancy. To investigate the association between first-trimester serum placental biomarkers and gestational duration, and to evaluate the independent effects of nulliparity and fetal sex on gestational length. This retrospective, single-center study included 346 singleton…
-
221.
Background and objective Beta-human chorionic gonadotropin (β-hCG) is an established biomarker in pregnancy assessment and in the management of trophoblastic and germ cell disorders. Beyond its classical endocrine role, β-hCG has biological relevance to inflammation, angiogenesis, endothelial function, immune regulation, and tissue remodeling, all of which are central to wound repair. The relationship between postoperative β-hCG decline and abdominal wound healing after cesarean section remains…
-
222.
To evaluate whether a modified double trigger (recombinant hCG -36 h plus GnRH agonist -34 h) improves oocyte maturation and embryological outcomes compared with r-hCG alone in IVF-ICSI cycles, and whether effects differ by age and ovarian reserve. Retrospective single-center cohort study included 80 IVF-ICSI cycles performed between 2023 and 2025, comparing a modified double trigger (n=42) with r-hCG alone (n=38). The primary outcome was oocyte maturation rate (MII/total oocytes). Secondary out…
- 223.
- 224.
-
225.
Cesarean scar pregnancy (CSP), a serious complication following cesarean section, may increase the risk of massive intraoperative bleeding and hysterectomy due to the implantation of the gestational sac at the uterine scar site. This study employed a prospective cohort analysis to investigate the diagnostic value of ultrasound parameters combined with estrogen levels for CSP in early pregnancy and its correlation with intraoperative bleeding volume during curettage. A total of 98 patients with C…
-
226.
Is trophectoderm re-biopsy for pre-implantation genetic testing for aneuploidy associated with lower serum beta-HCG (β-HCG) levels in early pregnancies resulting in live births? Retrospective cohort study (n = 280) of patients who underwent single frozen embryo transfer (FET) with a resulting live birth. β-HCG was measured on days 9 and 11 after FET. Covariate-based matching was carried out in a 1:3 ratio: re-biopsy (n = 40); single biopsy (n = 120); and no biopsy (n = 120). To evaluate pregnanc…
-
227.
The independent effect of paternal age on assisted reproductive technology outcomes remains uncertain, particularly when maternal characteristics and conventional semen parameters are considered. This study investigated the association between paternal age and embryological outcomes and β-hCG positivity in women with polycystic ovary syndrome (PCOS) undergoing intracytoplasmic sperm injection (ICSI). This single-center retrospective cohort study included 192 ICSI cycles in women with PCOS aged ≤…
- 228.
-
229.
To characterize the natural history of persistent low-level real human chorionic gonadotropin (hCG) after gestational trophoblastic disease (GTD) and identify predictors of subsequent gestational trophoblastic neoplasia (GTN). Retrospective cohort study included patients with persistent low-level real hCG (≤100 IU/L for ≥3 months) during postmolar surveillance or after GTN remission at specialized GTD referral centers in Rio de Janeiro, Brazil, between 2000 and 2022. Clinical characteristics, hC…
-
230.
The nano-LC-HRMS method previously developed for the analysis of human chorionic gonadotropin (hCG) glycoforms at the intact level involved trifluoroacetic acid (TFA) as ion-pairing agent in the LC mobile phase to favor separation, but resulted in both a significant decrease in the mass spectrometry (MS) signal and in complex mass spectra due to the presence of numerous adduct forms leading to a time-consuming manual data treatment and contributing to the MS signal decrease. To find the best bal…
- 231.
-
232.
Introduction Gestational trophoblastic disease (GTD) is characterized by abnormal trophoblastic proliferation, with hydatidiform mole being its most common form. Markedly elevated serum human chorionic gonadotropin (hCG) concentrations in molar pregnancy can stimulate thyroid-stimulating hormone receptors, resulting in thyroid dysfunction. This study aimed to evaluate thyroid hormone levels and their correlation with serum β-human chorionic gonadotropin (β-hCG) concentrations in patients with mo…
-
233.
This study aimed to identify key predictors of live birth and to develop a machine learning prediction model for women with unexplained recurrent spontaneous abortion (URSA) undergoing preimplantation genetic testing for aneuploidy (PGT-A). This retrospective study analyzed 127 patients with URSA who underwent PGT-A. Patients underwent frozen-thawed embryo transfer (FET) following either a hormone replacement cycle (HRT) or a down-regulated HRT. Data were collected on clinical baseline character…
-
234.
<h4>Background</h4>Undifferentiated pleomorphic sarcoma (UPS) is a high-grade, aggressive malignant tumour of fibrogenic origin, characterised by substantial cellular heterogeneity and poor prognosis. The lack of specific early clinical manifestations delays diagnosis and effective therapeutic intervention. In this study, we present a case of human chorionic gonadotropin beta subunit (hCGβ) expression in UPS.<h4>Materials and methods</h4>The presence of hCGβ was confirmed at both the mRNA and pr…
-
235.
Precise coordination between ovulation and insemination is essential for optimizing fixed-time artificial insemination (FTAI) in sows. This study compared ovulation timing and reproductive outcomes after treatment with recombinant human chorionic gonadotropin (rhCG), gonadorelin, or buserelin under estrus-triggered and fixed-time treatment protocols. A total of 285 sows received equine chorionic gonadotropin 24 h after weaning. In Trial 1, the ovulation-inducing treatments were administered at e…
Preprints (not yet peer-reviewed)
1-
236.
<title>Abstract</title> <p>OBJECTIVE To clarify whether dominant follicular proportion (DFP) on hCG trigger day is associated with oocyte maturation rate and low oocyte maturation rate across three widely used controlled ovarian hyperstimulation (COH) protocols in China, and to provide evidence for individualized trigger timing. STUDY DESIGN: A single-center, large-sample retrospective cohort study including 9,319 women undergoing their first fresh IVF or ICSI cycle between January 2021 and Janu…
Case Reports
7-
237.
An explanation is needed for why some men and women show positive in hCG screening tests when they are not pregnant, do not have cancer and are otherwise asymptomatic. In this study, a total of 10 families comprising 30 persons with a history of positive hCG tests were investigated. Total hCG was measured in serum and urine samples using the Siemens Immulite hCG test. Total hCG, C-terminal peptide determinant, and hCGβ were measured in 96 well plate assays. Twenty-four of 30 family members produ…
-
238.
Accurately interpreting persistent, low human chorionic gonadotropin (hCG) levels is essential for managing gestational trophoblastic disease. Erroneous interpretation can lead to inappropriate interventions, including unnecessary chemotherapy or hysterectomy, or unjustified changes in chemotherapeutic regimens due to misidentification of a false-positive hCG as a true positive. The predominant etiology of phantom hCG is the presence of heterophilic antibodies. Consequently, screening for urine…
-
239.
To provide clarity on the use of qualitative and quantitative human chorionic gonadotropin (hCG) tests for the assessment of pregnancy. A case scenario and a brief review of the relevant literature describing clinical and analytical considerations regarding hCG testing are presented. In pregnancy, hCG is nearly always detectable in serum and urine within 16 days after ovulation. Serial hCG testing is valuable in the evaluation of suspected ectopic pregnancy. hCG assays vary in their analytical s…
-
240.
Challenging clinical scenario in which elevated β-human chorionic gonadotropin (HCG, subsequently termed HCG) levels suggested occult tumor metastases after removal of bilateral testicular cancers and metastases from them and as well as after chemotherapy. A 22-year-old male, post excision of bilateral testicular tumors, who had no imaging or clinical evidence of residual tumor but an elevated HCG raising the question of the presence and location of occult tumor metastases. Clinical Questions. D…
-
241.
This case report investigates an unusual hCG result in a woman who is not pregnant. A 43-year-old woman was admitted for recurrence of thrombotic thrombocytopenic purpura (TTP) and therapeutic plasma exchange (TPE) was initiated. Prior to transitioning the patient from TPE to immunosuppressive therapy, a serum qualitative hCG test was performed and was positive. Several etiologies for elevated hCG were considered and investigated, including heterophile antibody interference, endogenous hCG from…
- 242.
-
243.
We report an exceptionally rare case of β-hCG-producing lung adenocarcinoma in a 23-year-old patient, likely among the youngest described to date. The patient presented with progressive respiratory symptoms and was initially managed as cancer of unknown primary following non-diagnostic biopsies. Subsequent biopsies of metastatic lesions demonstrated strong β-hCG expression, leading to an initial misdiagnosis of a germ cell tumor and initiation of BEP chemotherapy. Comprehensive molecular analysi…
Curated sources on file
26- 1.
- 2.
- 3.
- 4.
- 5.
- 6.
- 7.
- 8.
- 9.
- 10.
- 11.
- 12.
- 13.
- 14.
- 15.
- 16.
- 17.
- 18.
- 19.
- 20.
- 21.
- 22.
- 23.
- 24.
- 25.
- 26.